INS and type 2 diabetes mellitus: Ultra-long-acting insulin: An example would be insulin degludec.​​ It is a new ultra-long-acting insulin analog with a flat plasma glucose-lowering effect lasting for ~40 hours, suitable for meeting basal insulin requirements in patients with type 1 and type 2 diabetes.